COMPARISON TOOL
Compare peptides
Half-life, dosing, mechanism, status — side by side. Select up to four compounds, or start from a preset.
CJC-1295 + IpamorelinMax 4 peptides
| Property | CJC-1295 + Ipamorelin |
|---|---|
| Category | Growth |
| Type | Peptide blend |
| Mechanism | GHRH analog + selective GHRP (two-receptor GH pulse) |
| Status | Compounded (Rx) |
| Dosing range | 200–600 mcg total per dose |
| Frequency | Once nightly (up to 3× daily) |
| Half-life | ~30 min (CJC) / ~2 h (ipamorelin) |
| Route | Subcutaneous |
| Onset | 1–2 weeks (sleep); 6–12 weeks (composition) |
| Studied for |
|
| Key risks |
|
| Storage | Refrigerated (2–8 °C); use within the pharmacy beyond-use date |
| Available at G1 | Vials: 5/5 mg, 10/10 mgPens: Apex, Apex Plus, Trinity Stack, Fragment Apex, Lean RecoveryShop → |
| Tools | Dosage calculator → |
PROPERTY COMPARISON · RADAR
Profile shape
TYPICAL DOSE RANGES
Dose envelope
CJC-1295 + Ipamorelin200 mcg – 600 mcg
Typical per-dose range on a logarithmic scale. Your provider sets your dose.
For educational purposes only. Consult a licensed provider before starting any peptide protocol.